Active Pharmaceutical Ingredient (Generic)

PAZOPANIB

🩺 ANTINEOPLASTICS 💊 3 Marketed Brands
Clinical Profile:

*First-line treatment of advanced renal cell carcinoma, Treatment of advanced renal cell carcinoma in patients who have had previous treatment with cytokine therapy:* Adult: 800 mg daily, adjust dose in steps of 200mg according to tolerability; max. 800 mg per day. *Treatment of selective subtypes o...

Marketed Brands Containing PAZOPANIB (3) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
PAZONIX 🏢 HIMMEL
Tab 200 mg 30: Rs.71114.00
View Details →
VOPAZZI 🏢 MARTIN DOW
Tab 200 mg 30: Rs.40,401.00
Tab 400 mg 60: Rs.155,000.00
View Details →
VOTRIENT 🏢 NOVARTIS
Tab 200 mg 30: Rs.66250.00
Tab 400 mg 30: Rs.11,5938.00
View Details →